Zoetis (CHIX:ZOED) Short Interest


CHIX:ZOED Zoetis Inc CHIX:ZOED
66 GF Score
Price €66.44
GF Value €169.34
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CHIX:ZOED vs UTHR, VTRS, NBIX: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zoetis Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Short Interest distribution charts can be found below:

* The bar in red indicates where Zoetis's Short Interest falls into.


CHIX:ZOED
66GF Score
Zoetis Inc CHIX:ZOED
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zoetis (CHIX:ZOED) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of €66.44 is trading 60.8% below its estimated GF Value™ of €169.34. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for CHIX:ZOED:

  • Short Interest:
  • GF Value™: €169.34 vs. price of €66.44 (60.8% below fair value)
  • GF Score™: 66/100

No single metric tells the full story. See the CHIX:ZOED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
66GF Score

Get the complete analysis for CHIX:ZOED

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.44
Price
€169.34
GF Value